Ionian Technologies, Inc. has been awarded a $2.7 million contract for development of a rapid, hand-held biothreat detector. The device will have applications with military and civilian first responder personnel by enabling rapid and efficient response times to potential bioterrorist attacks. The EXPAR™ rapid detection technology used in the project was first discovered in the Galas Laboratory at the Keck Graduate Institute (KGI), Claremont, CA, one of the subcontractors on the project, and is licensed to Ionian. Northrop Grumman is the prime contractor for the program under the guidance of the Department of Defense’s (DoD’s) Defense Advanced Research Projects Agency (DARPA), through the Defense Microelectronics Activity’s (DMEA) Advanced Technology Support Program (ATSP2).
